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A Recommended Standard for Occupational Exposure to
DIBROMOCHLOBOPROPANE
The National Institute for Occupational Safety 
and Health (N IO S H ) recommends that employee 
exposure to dibromochloropropane in the workplace 
be controlled so that no worker will be exposed to 
dibromochloropropane in excess of 10 ppb (0.1 
m g/cu m ) in air. The N IO S H  recommendations is 
to restrict exposure to very low levels that can still 
be reliably measured in the workplace. T he recom­
mended exposure limit of 10 ppb is above the lowest 
level at which a reliable estimate of occupational ex­
posure to dibromochloropropane can be determined 
at this time. The recommended standard contains 
recommendations for medical surveillance, inform ing 
employees of hazards, sanitation, work practices, la­
beling and posting, personal protective clothing and 
equipment, monitoring and recordkeeping.
The recommended standard is designed to pro­
tect the health and provide for the safety of em­
ployees for up to a 10-hour shift, 40-hour workweek, 
over a working lifetime. Compliance w ith all sec­
tions of the standard should, at the minimum, sub­
stantially reduce adverse effects of exposure to dibro­
mochloropropane in the workplace. The employer 
should regard the recommended workplace environ­
mental lim it as the upper bondary for exposure and 
make every effort to keep the exposure as low as 
possible.
The possible effects on the health of employees 
chronically exposed to DBCP may include sterility, 
diminished renal function, and degeneration and cir­
rhosis o f the liver. In addition, ingestion of daily 
doses of DBCP by mice and rats has been found to 
result in the appearance of gastric cancers in both 
sexes of both species and in mammary cancers in 
female rats. A lthough an increased risk for cancer 
has not been seen with inhalation exposures, these 
results are not definitive, therefore the risk of cancer 
due to occupational exposure to DBCP remains a 
continuing concern. There are indications from in 
vitro experiments that mutagenic effects may occur 
also, but there has been no study yet of this possi­
bility with mammalian subjects. Employees should 
be told of these possible effects and inform ed that 
some 20-25 years of experience in the manufacture 
and formulation of DBCP has not yet called such 
effects in employees of the pesticide industry to the 
notice of physicians and epidemiologists. A more 
detailed review o f the known health effects are given 
in Enclosure 1.
The recommended standard is part of a continu­
ing series of recommendations developed by N IO SH  
in accordance w ith the Occupational Safety and Health 
Act of 1970. The recommended standard is being 
transmitted to the Departm ent o f Labor, September 
2, 1977, for review and consideration in the prepara­
tion of an emergency temporary standard. If  research 
by N IO SH  results in the development of improved 
methods for sampling and analysis of dibromochloro­
propane in air from  the occupational environment, 
inform ation regarding the new methods will be for­
warded to the Departm ent of Labor.
U. S. DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE 
Public Health Service 
Center for Disease Control
National Institute for Occupational Safety and Health
I. R EC OM M EN D A TIO N S FOR A TEM PORARY EM ERGENCY STA N D A R D  FOR 
O CC U PA TIO N A L EXPOSURE T O  DIBRO M O CH LO RO PROPA N E
The National Institute for Occupational Safety 
and Health (N IO S H ) recommends that employee 
exposure to dibromochloropropane (D B C P) in the 
workplace be controlled by adherence to the follow­
ing sections. The standard is designed to protect the 
health and provide for the safety of employees for 
up to a 10-hour work shift, 40-hour workweek, over 
a working lifetime. Compliance with all sections of 
the standard should, at the minimum, substantially 
reduce the effects of DBCP on the health of em­
ployees and provide for their safety. The employer 
should regard the recommended workplace environ­
mental limit as the upper boundary for exposure and 
make every effort to keep the exposure as low as 
possible. The criteria and standard will be subject to 
review and revision as necessary.
The possible effects on the health of employees 
chronically exposed to DBCP may include sterility, 
diminished renal function, and degeneration and 
cirrhosis o f the liver. In addition, ingestion of daily 
doses of DBCP by mice and rats has been found to 
result in the appearance of gastric cancers in both 
sexes of both species and in mammary cancers in 
female rats. Although an increased risk for cancer 
has not been seen with inhalation exposures, thesc- 
results are not definitive, therefore the risk of cancer 
due to occupational exposure to DBCP remains a 
continuing concern. There are indications from in 
vitro experiments that mutagenic effects may occur 
also, but there has been no study yet of this possibility 
with mammalian subjects. Employees should be told 
of these possible effects and informed that some 20-25 
years of experience in the manufacture and form ula­
tion of DBCP has not yet called such effects in 
employees of the pesticide industry to the notice of 
physicians and epidemiologists. A more detailed re­
view of the known health effects are given in En­
closure 1.
Sampling methods utilizing both charcoal and 
Florisil® tubes have been reported to N IO SH  as 
acceptable for measurements at the recommended en­
vironmental limit. However, an evaluation of the 
suggested methods has not yet been completed by 
N IO SH . Such a laboratory evaluation should be 
completed in the first part of FY 78.
"Occupational exposure to dibromochloropro­
pane” refers to any workplace situation in which 
DBCP is manufactured, formulated, or stored. All 
sections of the standard shall apply where there is 
occupational exposure to DBCP.
Section 1 —  Environmental (W orkplace A ir)
(a )  Concentration
Dibromochloropropane shall be controlled in the 
workplace so that no employee is exposed to airborne 
dibromochloropropane, at a concentration greater than 
10 parts per billion (approximately 0.1 m g/cu  m) 
determined as a time weighted average (T W A ) con­
centration for up to a 10-hour work shift, 40-hour 
workweek.
(b )  Sampling and Analytical M ethods
The environmental limit represents a concentra­
tion of dibromochloropropane measurable by reported 
sampling and analytical methods.
Section 2 —  Medical
Medical surveillance shall be made available to 
employees as outlined below:
(a ) Comprehensive preplacement or initial med­
ical and work histories with emphasis on reproductive 
experience and menstrual history.
(b )  Comprehensive physical examination with 
emphasis on the genito-urinary tract including testicle 
size and consistency in males.
(1 )  Semen analysis to include sperm count, 
motility and morphology.
(2 )  O ther tests, such as serum testosterone, 
serum follicle stimulating hormone (F S H ), and 
serum lutenizing hormone (L H ) may be carried 
out if, in the opinion of the responsible physician, 
they are indicated. In addition, screening tests o f the 
renal and hepatic systems may be considered.
(3 )  A judgment of the worker’s ability to 
use positive pressure respirators.
(c ) Employees shall be counseled by the physi­
cian to ensure that each employee is aware that DBCP 
has been implicated in the production of effects on 
the reproductive system including sterility in male 
workers. In addition, they should be made aware 
that cancer has been produced in some animals. W hile 
the relevancy of these findings are not yet clearly de­
fined, they do indicate that both employees and 
employers should do everything possible to minimize 
exposure to DBCP.
(d )  Periodic examinations containing the ele­
ments o f the preplacement or initial examination shall 
be made available on at least an annual basis.
(e) Examinations of current employees shall be 
made available as soon as practic?ble after the 
promulgation of a standard for DBCP.
( f )  Medical surveillance shall be made available 
to any worker suspected of having been exposed to 
DBCP.
(g )  Pertinent medical records shall be maintained 
for all employees subject to exposure to DBCP in 
the workplace. Such records shall be maintained for
at least 30 years after termination of employment. 
These records shall be made available to the desig­
nated medical representatives of the Secretary of 
Health, Education, and W elfare, of the Secretary of 
Labor, o f the employer, the employee, or former 
employee.
Section 3 —  Labeling and Posting
A label shall be placed on each shipping and 
storage container of dibromochloropropane and all 
areas where there is occupational exposure to 
dibromochloropropane shall be posted.
All warning signs shall be printed both in English 
and in the predom inant language of non-English- 
reading workers. Illiterate workers and workers read­
ing languages other than those used on labels and 
posted signs shall be informed of the hazardous 
areas and shall be informed of the instructions printed 
on labels and signs.
(a )  Labeling
Each container o f dibromochloropropane shall 
carry in a readily visible location a label stating:
D IBROM OCHLOROPROPANE
(Tradem ark, Common  Name, o r Chemical N am e)
W A R N IN G !!
B R EA TH IN G  VAPOR M AY BE HAZARDOUS 
T O  HEALTH  
CA N  BE FATAL IF SW ALLOW ED 
HARM FUL IF ABSORBED T H R O U G H  SKIN
Avoid breathing vapor.
Use only with adequate ventilation.
Keep containers closed whjsn not in use.
W ash thoroughly before eating, drinking, smoking, 
or using toilet.
I f  swallowed, induce vomiting immediately if patient 
is conscious. Call a physician.
(b )  Posting
W arning placards shall be affixed in readily vis­
ible locations in or near areas where there is occupa­
tional exposure to dibromochloropropane. The in­
formation shall be arranged as in. the following ex­
ample:
DIBRO M O CH LO RO PROPA N E
HARM FUL IF IN H A LED  
CA N  BE FATAL IF SW ALLOW ED
If respiratory protection is required in accordance 
with Section 4, the following statement in large let­
ters shall be added to the required sign:
RESPIRATORY PR O TEC TIO N  REQUIRED 
IN  TH IS  AREA
Section 4  —  Personal Protective Equipment and 
Clothing
(a )  Respiratory Protection
(1 )  Engineering controls shall be used w her­
ever needed to keep airborne dibromochloropropane 
concentrations below the recommended occupational 
exposure limit. Compliance with this limit may be 
achieved by the use of respirators under the following 
conditions only:
(A )  During the time necessary to install 
or test the required engineering controls.
(B ) For nonroutine operations, such as 
emergency maintenance or repair activities.
(C ) D uring emergencies when air con­
centrations of dibromochloropropane may exceed the 
recommended occupational exposure limit.
(2 )  W hen a respirator is permitted by para­
graph ( a ) ( 1 )  of this section, it shall be selected and 
used pursuant to the following requirements:
(A )  The employer shall ensure that no 
employee is exposed to dibromochloropropane be­
cause of improper respirator selection, fit, use, or 
maintenance.
(B ) The employer shall establish and en­
force a respirator program meeting the requirements 
of 29 CFR 1910.134 as amended.
(C ) The employer shall provide respira­
tors in accordance with Table 1-1 and shall ensure that 
the employee uses the respirator provided when 
necessary.
(D )  Respiratory protective devices de­
scribed in Table 1-1 shall be those approved under 
the provisions of 30 CFR 11.
(E ) Respirators specified for use in 
higher concentrations of dibromochloropropane may 
be used in atmospheres of lower concentrations.
(F )  The employer shall ensure that res­
pirators are adequately cleaned and maintained, and 
that employees are instructed and drilled, at least 
annually, in the proper use and testing for leakage 
of respirators assigned to them.
(G ) Respirators shall be easily accessible 
and employees shall be informed of their location.
(b )  Eye protection
Eye protection shall be provided by the employer 
and used by the employees where eye contact with 
liquid dibromochloropropane is likely. Selection, use, 
and maintenance of eye protective equipment shall be 
in accordance with the provisions of the American 
National Standard Practice for Occupational and Ed­
ucational Eye and Face Protection, ANSI Z 87 .1-1968. 
Unless eye protection is afforded by a respirator hood 
or facepiece, protective goggles [splash-proof safety 
goggles (cup-cover type dust and splash safety gog­
gles) which comply with 29 CFR 1910.133(a) (2 )  —
( a ) ( 6 ) ]  or a face shield (8-inch minim um ) shall
RESPIRATOR RECOMMENDATIONS FOR 
l,2 -DIBROMO-3 -CHLOROPROPANE
TABLE 1-1
CONCENTRATION PERMISSIBLE RESPIRATORY PROTECTION
U p to 50 times the PEL Any supplied-air respirator with a full facepiece, 
helmet or hood (30 CFR 1 1 .1 1 0 (A )).
Any self-contained breathing apparatus w ith a full 
facepiece (30 CFR 1 1 .7 0 (A )) .
50— 2,000 times the PEL A Type C supplied-air respirator with a full facepiece 
operated in pressure-demand or other positive pres­
sure mode with a full facepiece, hood or helmet oper­
ated in continuous flow mode (30 CFR 1 1 .1 1 0 (A )) .
50— 10,000 times the PEL Self-contained breathing apparatus w ith a full face­
piece operated in pressure-demand or other positive 
pressure mode (30 CFR 1 1 .7 0 (A )) .
A combination respirator which includes a Type-C 
supplied-air respirator w ith a full facepiece operated 
in pressure-demand or other positive pressure or con­
tinuous flow mode and an auxiliary self-contained 
breathing apparatus operated in pressure-demand or 
positive pressure mode (30  CFR 1 1 .7 0 (B )) .
Escape Any self-contained breathing apparatus (30  CFR 
1 1 .7 0 (A )) .
Any gas mask providing protection against organic 
vapors (30 CFR 11.90).
be worn at operations where there is danger of contact 
of the eyes with liquid dibromochloropropane be­
cause of spills or splashes. If there is danger of liquid 
dibromochloropropane striking the eyes from under­
neath or around the sides of the face shield, safety 
goggles shall be worn as added protection.
(c ) Protective Clothing
Protective clothing shall be resistant to the pene­
tration and to the chemical action of dibromochloro­
propane. Additional protection, including gloves, 
bib-type aprons, boots, and overshoes, shall be pro­
vided for, and worn by, each employee during any 
operation that may cause direct contact with liquid 
dibromochloropropane. Supplied-air hoods or suits 
resistant to penetration by dibromochloropropane shall 
be worn when entering confined spaces, such as pits 
or storage tanks. In situations where heat stress is 
likely to occur, supplied-air suits, preferably cooled, 
are recommended. The employer shall ensure that 
all personal protective clothing is inspected regularly 
for defects and is maintained in a clean and satis­
factory condition by the employee.
Section 5 —  Inform ing Employees of Hazards from 
Dibromochloropropane
(a )  All new and present employees working 
where occupational exposure to dibromochloropro­
pane may occur shall be informed orally and in w rit­
ing of the hazards, relevant signs and symptoms of 
exposure, appropriate emergency procedures, and 
proper conditions and precautions concerning safe use 
and handling of dibromochloropropane. This infor­
mation should be readily available to all employees 
involved in the manufacture, formulation, or storage 
of dibromochloropropane and shall be posted in 
prominent positions within the workplace.
(b )  All employees involved with the manufac­
ture, formulation, or storage of dibromochloropro­
pane shall be informed that it has been implicated in 
human reproductive abnormalities and has induced 
gastric cancers in animals following oral intubation.
(c) Employers shall institute a continuing edu­
cation program to ensure that all employees have cur­
rent knowledge of job hazards, maintenance pro­
cedures, cleanup methods, emergency procedures, and 
evacuation procedures. This program shall include at 
least :
Emergency procedures and drills.
Instruction in handling spills and leaks.
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Decont? minadon procedures.
Location and use of firefighting equipment.
First-aid procedures, equipment location, 
and use.
Rescue procedures.
Confined space entry procedures.
Records of such training shall be kept for inspection 
by authorized personnel as required. This program 
shall be held for all employees with occupational 
exposure to dibromochloropropane at intervals not 
greater than quarterly, or whenever there is a process 
change.
( d )  Inform ation as required shall be recorded 
on the "M aterial Safety Data Sheet,” or on a simi­
lar form approved by the Occupational Safety and 
Health Administration, U.S. Departm ent o f Labor.
Section 6 —  W ork Practices
(a )  Emergency Procedures 
For all work areas where emergencies may occur, 
the employer shall take all necessary steps to ensure 
that employees are instructed in and follow the pro­
cedures specified below and any others appropriate 
to the specific operation or process.
(1 )  Procedures shall include at least pre­
arranged plans for re-entry into areas where dibromo­
chloropropane leaks or spills have occurred for clean­
up, decontamination, or maintenance purposes.
(2 )  Evacuation alarm systems shall be pro­
vided by the employer.
(3 )  Personal protective equipment and cloth­
ing as specified in Section 4 shall be used by trained 
personnel essential to emergency operations.
(4 )  Nonessential employees shall be evacu­
ated from hazardous areas during emergencies. Per­
imeters o f these areas shall be delineated, posted, and 
secured. The employees in adjacent areas shall be 
trained in evacuation procedures if these work areas 
become involved.
(5 )  O n!/ personnel trained in the emer­
gency procedures and protected against the attendant 
hazards shall shut off sources of dibromochloropro­
pane, clean up spills, control and repair leaks, and 
fight fires in dibromochloropropane areas.
(6 )  F.refighting procedures shall be estab­
lished for areas where flammable materials are used 
w ith dibromochloropropane. Chemical foam, carbon 
dioxide, or dry chemicals shall be used for fighting 
fires in areas where dibromochloropropane is present. 
Proper protective respirators and clothing shall be 
worn by all personnel in the hazard area until con­
centrations of airborne dibromocholorpropane have 
been demonstrated by monitoring to be below the 
recommended occupational exposure limit.
(7 )  Showers, eyewash fountains, and wash­
room facilities shall be provided and so located as to 
be readily accessible to workers in all areas where skin 
or eye contact with liquid dibromochloropropane is 
likely. If liquid dibromochloropropane is splashed 
on the clothing or skin, contaminated clothing shall 
be promptly removed and the skin washed thoroughly 
with soap and water. If liquid dibromochloropropane 
gets into the eyes, they shall be irrigated immediately 
with copious quantities of running water.
(8 )  Medical attention shall be provided 
promptly for any affected worker. Such exposures 
shall be reported to the immediate supervisor by the 
affected worker or by a fellow employee.
(b )  Control o f A irborne Dibromochloropropane
(1 )  Suitable engineering controls designed
to limit exposure to dibromochloropropane to that 
prescribed in Section 1 (a )  shall be used. The use of 
completely enclosed processes is the recommended 
method of control for dibromochloropropane. Local 
exhaust ventilation may also be effective, used alone 
or in combination w ith process enclosure. W hen a 
local exhaust ventilation system is used, it shall be 
designed to prevent the accumulation or recirculation 
o f ventilation control or process air in the work­
room, to maintain dibromochloropropane concentra­
tions below the limit of the recommended standard, 
and to remove dibromochloropropane from  the breath­
ing zones of employees. Exhaust systems discharging 
into outside air must conform with applicable local, 
state, and federal air pollution regulations. Ventila­
tion systems shall be subjected to regular preventive 
maintenance and cleaning to ensure effectiveness, 
which shall be verified by periodic airflow measure­
ments at least every 3 months. Measurements of sys­
tem efficiency shall also be made immediately by 
personnel properly attired in specific protective equip­
m ent when any change in production, process, or con­
trol might result in increased concentrations of air­
borne dibromochloropropane. Tempered makeup air 
shall be provided to work areas in which exhaus 
ventilation is operating.
(c) H andling of Dibromochloropropane and 
General W ork Practices
(1 )  W ritten operating instructions and emer­
gency medical procedures shall be form ulated and 
posted where dibromochloropropane is handled or 
used.
(2 )  Prompt medical attention shall be pro­
vided if there is known or suspected exposure to 
dibromochloropropane, whether or not symptoms are 
present.
(3 )  The employer shall ensure that safety 
showers, eyewash fountains, and other emergency 
equipment is in proper working order through reg­
ularly scheduled inspections perform ed by qualified 
maintenance personnel.
(4 )  D ibromochloropropane operating systems 
shall be inspected daily for signs of leaks by person­
nel attired in specified protective equipment. All 
equipment including valves, fittings, and connections 
shall be checked for tightness and good working 
order. All newly made connections shall be checked 
for Jeaks immediately after dibromochloropropane is 
introduced by trained personnel attired in prescribed 
personal protective equipment.
(5 )  If  there is a leak, the leak shall be cor­
rected immediately. W ork shall resume normally 
only after necessary repair or replacement has been 
completed, the area has been ventilated, and the 
concentration of dibromochloropropane has been de­
termined by monitoring to be below the recommended 
occupational exposure limit.
(6 )  Transportation and use of dibromo­
chloropropane shall comply with all applicable local, 
state, apd federal regulations. Strict adherence to 
the pesticide container label requirements for appli­
cation and personal protection shall be followed. 
Additional standards for pesticide use by agricultural 
workers can be found in 40 CFR 170.
(7 )  W hen dibromochloropropane containers 
are being moved, or when they are not in use and 
are disconnected, valve protection covers shall be in 
place. Containers shall be moved only with the 
proper equipment and shall be secured to prevent 
dropping or loss of control while moving.
(8 )  Process valves and pumps shall be read­
ily accessible and should not be located in pits and 
congested areas.
(9 )  Containers and systems shall be handled 
and opened with care. Approved protective equip­
m ent as specified in Section 4 shall be worn while- 
opening, connecting, and disconnecting dibromo­
chloropropane containers and systems. Adequate 
ventilation shall be available to prevent exposure to 
dibromochloropropane when opening containers and 
systems.
(1 0 ) Personnel shall work in teams when d i­
bromochloropropane is first admitted to a system, 
while repairing leaks, or when entering a confined 
or enclosed space.
(d )  W ork Areas
(1 )  Dibromochloropropane Hazard Areas
A hazard area shall be considered as any space 
workers may enter that has physical characteristics 
and sources of dibromochloropropane that could re­
sult in air concentrations exceeding the recommended 
limit. Exits shall be plainly marked and shall open 
outward. Emergency exit doors shall be conveniently 
located and shall open into areas which will remain
free of contamination in an emergency. A t least two 
separate means of exit shall be provided from  each 
room or building in which dibromochloropropane is 
stored, handled, or used in quantities that could 
create a haza'rd.
(2 )  Confined or Enclosed Spaces
Entry into confined spaces, such as tanks, pits, 
process vessels, tank cars, sewers, or tunnels, where 
there may be limited egress shall be controlled by a 
permit system. Permits shall be signed by an author­
ized employer representative certifying that preven­
tive and protective measures have been followed.
Confined spaces which have contained dibromo­
chloropropane shall be thoroughly ventilated to en­
sure an adequate supply of oxygen, tested for dibro­
mochloropropane and other contaminants, and 
inspected for compliance with these requirements 
prior to each entry. Adequate ventilation shall be 
maintained while workers are in the space. Leakage 
of dibromochloropropane into the confined space 
while work is in progress shall be prevented by dis­
connecting and blanking the dibromochloropropane 
supply lines. An individual entering confined spaces 
shall be furnished with appropriate personal protec­
tive equipm ent and protected by a lifeline harness 
tended by another worker outside the space, who 
shall also be equipped for entry with approved per­
sonal protective equipment and who has contact 
w ith a third party. Communication (visual, voice, 
signal line, telephone, radio, or other suitable means) 
shall be maintained by the standby person with the 
employee inside the confined or enclosed space. A 
third employee, equipped to proceed to the aid of the 
other two if necessary, shall have general surveillance 
of their activities.
(e )  Storage
(1 )  Storage facilities shall be designed to 
contain spills completely within a surrounding dike 
and to prevent contamination of workroom air.
(2 )  Storage of dibromochloropropane in the 
same area as reactive metals, such as aluminum or 
magnesium, or as liquid ammonia shall be pro­
hibited.
(3 )  Storage containers shall be periodically 
inspected for leakage.
(4 )  Ventilation switches and emergency res­
piratory equipm ent shall be located outside storage 
areas in readily accessible locations which will be 
free of dibromochloropropane in an emergency.
( f )  Spills, Leaks, and W aste Disposal
(1 )  If  dibromochloropropane leaks or is 
spilled, the following steps shall be taken:
(A ) Evacuate all nonessential person­
nel from the area.
(B ) Adequately ventilate the area of the
(C ) If  in liquid form, collect spilled ma­
terial for reclamation or absorb in vermiculite, dry 
sand, earth, or similar nonreactive material.
(D )  If in solid form, collect spilled ma­
terial in the most convenient and safe manner for 
reclamation or for disposal.
(2 )  Personnel entering the spill or leak area 
shall be furnished with appropriate personal protec­
tive equipment. All other personnel shall be ex­
cluded from the area.
(3 )  AH wastes and residues containing di- 
bromochloropropane shall be collected in dibromo- 
chloropropane resistant containers and incinerated or 
buried in such a manner that no dibromochloropro- 
pane or toxic decomposition products are released to 
the environment.
Section 7 —  Sanitation Practices
(a )  Plant sanitation shall meet the requirements 
of 29 CFR 1910.141.
(b )  A ppropriate locker rooms shall be available 
for changing into required protective clothing in ac­
cordance with 29 CFR 1910 .141(e). C lothing con­
taminated with liquid dibromochloropropane shall be 
immediately removed and placed in a closed container 
in a well-ventilated area for later disposal or decon­
tamination. Employers shall require personnel who 
work w ith dibromochloropropane to shower before 
leaving the workplace at the end of a workday.
(c ) Employers shall ensure that employees who 
handle dibromochloropropane wash their hands 
thoroughly with soap and water before eating, smok­
ing, or using toilet facilities.
(d )  The storage, dispensing, preparation, and 
consumption of food, beverages, or tobacco shall be 
prohibited in dibromochloropropane work areas.
(e )  The employer shall ensure that personnel 
who launder and clean clothing or equipment con­
taminated with dibromochloropropane are provided 
adequate personal protective equipm ent to prevent 
exposure and shall ensure that these employees are 
aware of the potential hazards of exposure to di­
bromochloropropane.
Section 8 —  M onitoring and Recordkeeping 
Requirements
(a )  Industrial hygiene surveys shall be made in 
any workplace where dibromochloropropane is han­
dled, processed, or stored. Records of these surveys, 
including the basis for concluding that environmental 
concentrations are below the recommended limit shall 
be maintained. Surveys shall be repeated every month 
or whenever a process change is made.
(b )  W here exposure concentrations have not
spill or leak to prevent accumulation o f the vapor. been determined, they shall be determined as soon as 
practicable after the promulgation of a standard based 
on these recommendations.
(c ) Requirements set forth below apply to work 
areas where there is occupational exposure to dibro­
mochloropropane.
(1 )  An adequate number of samples shall be 
collected monthly for the evaluation of the work 
environment with respect to the occupational expo­
sure of the employees.
(2 )  Environmental samples shall be taken 
when a new process is installed or process changes 
are made which may cause an increase in environ­
mental concentrations. Significantly increased pro­
duction, relocation of existing operations, interrup­
tion of normal maintenance schedules, or other func­
tion which may increase dibromochloropropane con­
centrations shall require resampling and analysis.
(3 )  The minimum number of representative 
exposure determinations for an operation or process 
shall be based on variations in exposures and pro­
duction schedules and in accordance with the provi­
sions prescribed in Section 1 (b ) .
(4 )  If  initial, periodic, or special evaluations 
indicate that the recommended limit is exceeded, cor­
rective engineering or other control measures shall be 
immediately instituted to ensure the safety of em­
ployees until a concentration below the occupational 
exposure limit is achieved. In such cases, sampling of 
each operation and work location shall be conducted 
until two consecutive employee exposure measure­
ments, taken at least 1 week apart, reveal that the 
employee is not exposed to dibromochloropropane 
above the recommended occupational exposure limit. 
Employers shall notify in writing, within 5 days, 
every employee who is found to be exposed to di­
bromochloropropane above the recommended environ­
mental limit.
(d )  Employers or their successors shall maintain 
records which shall include sam pling and analytical 
methods, types of respiratory protection used, con­
centrations found, and inform ation concerning ex­
posure of employees to dibromochloropropane. Each 
employee shall have access to data on his or her own 
environmental exposures. Pertinent records of occu­
pational accidents and environmental exposures 
w ithin the workplace shall be kept for at least 30 
years after the worker’s employment has ended. Rec­
ords of occupational exposures applicable to an em­
ployee should be included in that employee’s medical 
records. The medical representatives of the Secre­
tary of Health, Education, and W elfare, of the Sec­
retary of Labor, of the employee or former employee, 
and of the employer shall have access to all such 
records.
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IA P P E N D IX  I
M E T H O D  FO R  S A M P L IN G  
D IB R O M O -C H L O R O P R O P A N E  IN  A IR
The following method is based on detailed reports 
from two representatives of the Shell Development 
Company. These reports have been communicated 
only by telephone. The method has not been pub­
lished and has not been evaluated in N IO SH  labora­
tories. The method has been tested by Shell with 
a number of field samples.
Procedure
1. An air sample is collected on a tube of Florisil.®
2. If the samples cannot be analyzed immediately 
after collection, the samples should be stored at 
— 200°C. The refrigerated samples may be stored 
for two weeks or less.
3. The l,2-dibromo-3-chloropropane is desorbed 
from the Florisil® with hexane.
4. Analysis is accomplished with a gas chromato­
graph equipped with an electron-capture detector.
Useful Range
The method is applicable to air concentrations 
ranging from  1 to 100 parts per billion (0.01 to 1 
m g/cu  m ).
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A T T A C H M E N T  I
LITERATURE REVIEW FOR DIBROMOCHLOROPROPANE
Background: 1 ,2 -d ib ro m o - 3 - c h lo r o p r o p a n e
(D B C P) has the formula CH.,Br-CHBr-CH2C l. It 
has a gram molecular weight of 236.36. An amber 
to brown liquid with a pungent odor, DBCP has a 
specific gravity of 2.09 at 14°C referred to water. 
It has an index of refraction of 1.553 at 14°C for 
the D-line of the emission spectrum of sodium. 
DBCP has a vapor pressure of less than 1 mm of Hg 
at 21°C and boils at 199°C under a pressure of 760 
mm of Hg. It is miscible with aliphatic and aromatic 
hydrocarbons, isopropyl alcohol, 1,2-dichloropropane, 
tetrachloroethylene, 1,1,2-trichloroethane, and oils. 
The undiluted material has no flash nor fire point. 
Because DBCP has been diluted commonly with kero­
sene or other flammable solvents, the preparations 
available in the market place may have flash points in 
the vicinity of 35-36°C (Tagliabue closed cup).
DBCP has been used in agriculture as a nema- 
tocide since 1955, being supplied for such use in the 
forms of liquid concentrate, emulsifiable concentrate, 
powder, granules, and solid material. Formulations 
of DBCP were registered for use as fumigant nema- 
tocides in 1964 on evidence that residues of the 
material as such would not remain on harvested raw 
agricultural commodities and that the only residue 
would consist of inorganic bromides. Newsome et al. 
(1977) reported, however, that substantial amounts 
of DBCP were found in radishes (up  to 0.20 ppm ) 
and carrots (up  to 1.55 ppm in roots and 0.64 ppm in 
the tops) grown in soil treated with this fumigant. 
The estimated use of DBCP in the United States in 
recent years has ranged from 3.6 million pounds in 
1971 to 12.3 million pounds in 1972 (USDA esti­
mates) .
In 1971,‘ more than 59%  of the DBCP used was 
applied in the Pacific Coast states (Andrilenas, 
1974). The material is sold under such names as 
Nemagon, Fumazone, Nemafume, Nemaset, and 
Nematox.
On August 5, 1977, the National Institute for 
Occupational Safety and Health (N IO S H ) was re­
quested by the Oil, Chemical and Atomic W orkers 
(O C A W ) union to conduct a health hazard evalua­
tion at the Oxidental Chemical Company plant in 
Lathrop, California. This request was made when 
representatives of O C A W  learned that a number of 
workers at this plant had abnormally low sperm 
counts.
On August 9 and 10, N IO SH  conducted a walk­
through inspection of the Lathrop plant and met 
with representatives from the company, the local
union, and California OSHA. N IO SH  staff also met 
with Dr. W horton, Univ. of Calif., Berkeley, who 
had consulted with the company and the union previ­
ously and who had conducted medical examinations 
o f the affected employees. Medical examinations of 
a number of additional employees have subsequently 
been conducted by N IO SH  staff in conjunction with 
Dr. W horton.
On August 12, the Occupational Safety and 
Health Administration in a telegram alerted approxi­
mately 80 manufacturers and formulators to the po­
tential hazard of worker exposure to DBCP. On 
August 23, a guideline document detailing suggested 
work practices was forwarded to these same affected 
companies.
On August 19, the Director, N IO SH , wrote to 
the major manufacturers o f DBCP requesting infor­
mation to fully evaluate the extent of the hazard 
posed by exposure to DBCP.
A nim al Toxicity. Torkelson et al. (1961) re­
ported that results of studies of the toxicity of DBCP 
for various species of animals by two different labora­
tories (A  and B ). Rakhmatulayev (1971) also has 
reported the results of similar studies. The various 
estimates of oral LD50 values for different species are 
listed below in m g/kg :
Torke/son et al.
A  B
Female Mouse 260 410
Male Rat 170 300
Rat
Male Guinea Pig 210
Guinea Pig
Male Rabbit 180
Rabbit
Chicken 60
Rakhmatulayev listed the effects o f lethal doses as 
being brief central excitation followed by depression, 
analgesia, uncoordinated activity of skeletal muscles, 
and paralysis of limbs.
Torkelson et al. (1961) reported also that DBCP 
as a 1 r/c solution in propylene glycol or as undiluted 
liquid dropped into conjunctival sacs of rabbits' eyes 
produced slight irritation and pain of the conjunctivae 
and iris. These effects disappeared after 1-2 days. 
W ashing the eyes with water 30 seconds after contact 
with DBCP did not alter the conjunctival and iridial 
responses.
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Rakhmatulayev
350
316
440
Applications of 0.5 ml of DBCP to the shaven 
backs of 4 rabbits produced slight erythema in 
abraded areas of skin and no signs of irritation in 
intact skin (Torkelson et al., 1961). Repetition of 
such applications resulted in only a slight crustiness 
of the skin after 20 applications. The dermis and 
subcutaneous tissue at the site of application in one 
rabbit had extensive necrosis and infiltration with 
polymorphonuclear leucocytes upon microscopic ex­
amination. An unspecified number o f other rabbits 
subjected to repeated, covered applications of a lO'/r 
solution of DBCP in the methylether of dipropylene 
glycol to their shaven bellies, the applications being 
renewed every 24 hours up to a total of 10 applica­
tions, had no lesions other than slight hyperemia and 
scaliness of the skin at the site of application. Per­
cutaneous LD 50’s for the rabbit were 1400 m g /kg  
when undiluted DBCP was applied for 24 hours and 
500 m g /k g  when DBCP was applied as a 10%  solu­
tion in propylene glycol.
Rats reported by Torkelson et al. (1961) to have 
been exposed to vaporized DBCP were observed to 
become apathetic, sluggish and ataxic but not to be 
completely narcotized. Clouding of the cornea or 
lens was seen with exposures to the higher concentra­
tions (up  to about 400 p p m ). Laboratory A found 
that the LC50 fell from about 400 ppm with a 1-hour 
exposure to one of about 110 ppm for a 7-hour expo­
sure. Laboratory B did not estimate LC50’s but ob­
tained mortalities in groups of rats that suggest a 
relationship between duration of exposure and LC50 
fairly similar to that found by laboratory A within 
the range of durations of exposure used by the latter 
group. Laboratory B found that a concentration of 
about 290 ppm killed 2 /1 2  rats at an exposure dura­
tion of 12 minutes, 3 /1 2  rats at one of 30 minutes, 
and 3 /1 2  rats at one of 60 minutes. These values 
suggest, but do not demonstrate, that the same 
straight line relationship between log concentration 
and duration of exposure found by Laboratory A for 
durations of 1 to 7 hours may not obtain with dura­
tions of exposure less than 1 hour.
Fifty inhalation exposures lasting for 7 hours, 
5 days/week, o f male rats to a concentration of 
DBCP of 5 ppm killed 0 /1 5  animals, one to 10 
ppm  killed 2 /1 5 , and one to 20 ppm killed 10 /15. 
Even the lowest of these concentrations produced a 
decrease of 18.6%  in the mean weight o f the testes. 
This was not a statistically significant decrease. Ex­
posure to the next higher concentration (10 ppm ) 
produced a statistically significant decrease (4 9 .0 % ) 
in the mean weight of the testes. Exposure to that 
concentration also resulted in a significant increase 
in the weight of the kidney (3 1 .7 % )- These studies 
were perform ed by Laboratory A (Torkelson et al., 
1961).
Laboratory B (Torkelson et al., 1961) exposed 
male and female rats to 50 7-hour exposures to 12 
ppm of DBCP. These exposures resulted in the 
deaths of 8 /2 0  male and of 10 /20  female rats, de­
generative changes in the seminiferous tubules, reduc­
tion in the number of sperm cells, increase in the 
proportion of abnormal sperm cells, increase in the 
number of Sertoli cells in the males, significant in­
creases in the weights of the kidneys in both sexes 
with cloudy swelling of the epithelium of the proxi­
mal convoluted tubules and increased amounts of 
interstitial tissue in the kidneys of the males, and 
dilatation of the sinusoids and centrilobular conges­
tion in the livers of both sexes.
Laboratory B (Torkelson et al., 1961) also gave to 
guinea pigs and rabbits 66 7-hour exposures to va­
porized DBCP in a concentration of 12 ppm. These 
exposures killed no animals but did result in statis­
tically significant decreases in the mean weights of the 
testes in both species. Two female monkeys exposed 
for 50 and 60 times, respectively, to 12 ppm of 
DBCP developed severe leukopenias and anemias. 
The concentrations of bromide in the sera of the ex­
posed rats, guinea pigs, and rabbits ranged between 
6.7 and 12.8 m g/100  ml whereas those of the control 
animals o f these 3 species ranged from 0 to 7.8 
m g /100 ml.
Torkelson et al. (1961) reported also the results 
from a 90-day feeding study with rats of both sexes. 
The concentrations of DBCP in the diet were 0, 5, 20, 
50, 150, 450, and 1350 ppm. The kidneys of female 
rats fed diets with concentrations of 20 or more ppm 
of DBCP and the livers o f those fed diets containing 
450 or more ppm were significantly heavier than those 
of the controls. Only those males fed the diet includ­
ing 1350 ppm of DBCP had kidneys and livers sig­
nificantly heavier than those of the controls.
These studies revealed that DBCP had two out­
standing toxic effects in subacute exposures: an anti- 
spermiogenic effect in the male and a nephrotoxic 
effect that occurred in both sexes of the rat, but espe­
cially in the female. Laboratory B was able to show 
that neither the adrenocorticotropic hormone 
(A C T H ), cortisone, nor testosterone altered bene­
ficially the effect of DBCP on the testes. Indeed, 
testosterone enhanced the atrophic effect of DBCP.
The final bit of inform ation in the paper by 
Torkelson et al. (1961) was that men given brief 
exposure to a concentration of 1.7 ppm of DBCP 
described a definite, not unpleasant, odor. The auth­
ors recommended that occupational exposure to DBCP 
be controlled to hold the airborne concentration of 
the nematocide below 1 ppm.
Rakhmatulayev (1971) also reported results from 
a subacute (2 l/2 months’ duration) and a chronic 
(8  m onths’ duration) experiment using rats and
administering DBCP by mouth in doses of 17.5-70 
m g 7kg (subacute) and .0005-5 m g /k g  (chronic). 
The most sensitive indicators of toxic activity by 
DBCP in these experiments were reductions in the 
weight of the testes and in duration of motility of 
spermatozoa, decreased avidity of leucocytes for en­
gulfing bacteria and decreased rate of positive con­
ditioning. These effects were present with the dose 
of 0.05 m g/kg, but not with that of 0.005 m g/kg , 
in the chronic exposure study.
Faydysh (1973) performed another study of the 
effect of prolonged administration (5 m onths) of 
DBCP in oral doses of 0.05, 0.5, and 5.0 m g/kg . The 
two highest doses were observed to decrease both the 
activity of neutrophils in engulfing and digesting 
bacteria and the concentration of these cells in the 
blood. These results confirm the report of Rakhma- 
tulayev (1971) mentioned just above. Because pha- 
gocytically-mediated immunity is one of the defensive 
mechanisms of the body against conditions related to 
proliferation of abnormal cells, these effects of 
DBCP may contribute to the carcinogenic activity of 
this compound in experimental animals.
Faydysh et al. (1970) and Faydysh and Avkhi- 
menko (1974) studied further the effects of DBCP 
on testicular function. In the first study, 10 male 
rats were given daily oral doses of 70 m g /k g  of 
DBCP in sunflower seed oil. Ten other male rats 
were given corresponding volumes of the sunflower 
seed oil alone. Five of the rats given DBCP died 
between days 20 and 25 of the experiment; the other 
5 lived through the 45 days of the experiment. At 
necropsy, all internal organs were pallid and the 
gastric mucosa was noted to have been thinned. 
Although the blood was not examined specifically, 
the authors’ description of the general appearance 
of the internal organs and of the vascular system 
raises a suspicion that there was marked anemia. 
The major parenchymatous organs, particularly the 
liver and kidneys, and the testes had undergone p ro­
nounced necrotic effects. The livers contained areas 
of cirrhosis replacing necrotised tissue and the spleens 
had areas of necrosis in both the white and the red 
pulps. The parenchyma destroyed in the testes also 
was replaced by scar tissue. Some regenerative ac­
tivity was visible in the parenchymatous organs. The 
second paper demonstrated that similar changes could 
be accomplished by a daily dose of 0.5 m g /k g  given 
during a longer period of time. This suggests that 
DBCP exerts some relatively, or possibly completely, 
irreversible action that eventually accumulates to pro­
duce a deleterious effect on target organs.
Reznik and Sprinchan (1975) studied the gona­
dotropic actions of DBCP in both male and female 
rats. Single oral doses of 100 m g /k g  or daily doses 
of 10 m g/kg , administered for 4 to 5 months, were 
used. The single dose produced w ithin one week a
decrease in the sperm count in the semen from 
4 .9± 0 .2  m illion /m g to 2 .6±0 .3  million /m g. A t the 
same time, there was a decrease in the duration of 
mortility of the spermatozoa from  about 31 minutes 
to about 15 minutes. In the females, the estrus cycle 
was prolonged, both estrus and diestrus becoming 
longer.
The repeated doses o f DBCP eventually pro­
duced effects similar to those that followed the single 
large dose. By the fourth m onth of administration, 
the concentration of spermatozoa in the semen was 
2 .5±0.5  m illion /m g vs 4 .9± 0 .3  m illion /m g  in the 
controls and the duration of motility of the sperma­
tozoa Was 29 minutes whereas that of spermatozoa 
from ,control rats was 51 minutes. D uring the first 
month of daily doses, 24%  of the females developed 
atypical estrus cycles; by the fifth month, this figure 
rose to 70% . At the same time, the duration of the 
cycles increased; 57%  of the females became acyclic 
by the fifth month. It is apparent, therefore, that 
an effect on sperm count in the male may not be the 
only effect on human fertility from occupational ex­
posure to DBCP and that the possibility of induction 
of sterility in female employees needs to be con­
sidered also.
N o experimental study of teratogenic or muta­
genic activities by DBCP in mammals has been found. 
Rosenkranz (1975) examined the effects of this sub­
stance on two strains o f E. coli and on two of the 
tester strains o f Salmonella typhim urium: TA  1530 
and TA  1538. DBCP was mutagenic for the first of 
these tester strains but not for the second, indicating 
that it induces mutations of the base-substitution but 
not of the frame-shift type. The finding that DBCP 
inhibited growth of a strain of E. coli deficient in 
D N A  polymerase to nearly 2.4x the extent o f its in­
hibition of that of a strain with a normal complement 
of the polymerase indicates that its principal effect is 
on the D N A . These results are reminiscent of those 
of Vogel and Chandler (1974) in which they found 
that 1,2-dibromopropane was definitely mutagenic 
in Drosophila. As pointed out by these latter auth­
ors, the important property of vicinal 1,2-dibromides 
is that in solution they readily rearrange to form  the 
very reactive bromonium ions. This ability would 
not be modified importantly by substitution of a 
chlorine atom on the third carbon of propane.
The N ational Cancer Institute undertook in 1972 
studies of the possible carcinogenicity of DBCP, as 
one of a group of halogenated compounds. As early 
as 14 weeks after the initiation o f administration by 
stomach tube of daily doses of 24 m g /k g  of DBCP 
dissolved in corn oil, 5 times per week, several 
female rats were found to have palpable mammary 
tumors (O lson et al., 1973). Female rats given daily 
doses of 12 m g /k g  of DBCP had not developed 
mammary tumors. A fter the fourteenth week, the
closes were increased to 30 and 15 m g /kg /day . These 
doses were continued up to a total duration of the 
experiment o f 54 weeks. D uring this period, 7 males 
and 11 females of the 50 rats of each sex given each 
dose of DBCP used in the experiment died without 
tumors. Seventeen of the male rats and 33 of the 
females given the high dose developed squamous 
carcinomas of the forestomach and 12 of the females 
had adenocarcinomas of the breast. Five female rats 
given the low dose of DBCP developed mammary 
carcinomas and 4 males and 14 females developed 
gastric carcinomas. One male among the 20 rats of 
each sex used as vehicle controls developed a tumor 
that was not described more specifically. Groups of 
50 male mice given 160 or 80 m g /k g /d ay  of DBCP 
for 14 weeks, 200 or 100 m g /k g /d ay  for the next
13 weeks, and 260 or 130 m g /k g /d ay  for 25 weeks 
and numerically similar groups of female mice given 
120 or 60 m g /k g /d ay  for the first 14 weeks and 
thereafter given the same doses as the males developed
14 gastric carcinomas in males and 9 in females on 
the high dose, and 3 in each sex on the low dose of 
DBCP. N o  mammary carcinomas developed in the 
female mice and no tumors of any sort developed in 
the vehicle controls (20 of each sex for each species).
A report in abstract form  (Powers et al., 1975) 
at a later stage of the same study (after 78 weeks) 
changed the results in a quantitative way only, the 
incidence of mammary adenocarcinoma in female 
rats increasing to 54%  and that of squamous cell 
carcinoma of the stomach exceeding 60%  in the rats 
and 90%  in the mice.
A draft o f the final report o f the contractor 
(Hazleton Laboratories America, 1977) to the N a­
tional Cancer Institute reveals that male B6C3F1 mice 
received 160 or 80 m g /k g /d a y  of DBCP by gavage 
for 11 weeks, 200 or 100 m g /k g /d ay  for 14 weeks 
and 260 or 130 m g /k g /d a y  for 22 or 33 weeks, 
respectively. The time weighted average daily doses 
were 219 m g /k g  for the high-dose group and 113 
m g /k g  for the low-dose group. The female mice of 
the same strain received 120 or 60 m g /k g /d ay  during 
the first 11 weeks and thereafter received the same 
doses as the males. The time-weighted average doses 
for the females were 209 m g /k g  and 109 m g/kg . 
Osborne-Mendel rats of the two sexes were given 
identical doses: 24 or 12 m g /k g  for the first 9 
weeks, 15 m g /k g  for 60 weeks (m ales) or 64 weeks 
(fem ales), followed by a 5-week observation period 
for the males, for the low-dose group, and 30 m g /k g  
for 55 weeks for the high dose group. For both male 
and female rats, the time-weighted average daily 
doses, 5 days/week, were 15 m g /k g  for the low dose 
group and 29 m g /k g  for the high dose one.
T he preliminary estimates are that the growth of 
male mice decreased slightly after the first 8 weeks on
the high dose and after 22 weeks on the low dose. 
The growth of the females may have decreased after 
32 weeks on the high dose. Mortality among the 
male mice increased after 36 weeks on the high dose 
and after 38 weeks on the low dose; that among the 
females increased after 36 weeks on the high dose 
and after 43 weeks on the low dose. The incidences 
of gastric cancer in male mice were 93.5%  on the 
low dose and 97.9%  on the high dose. N o other 
tumors were reported in the mice but toxic nephro­
pathy was found in 23.8%  and 93.8%  of male mice 
on the low and high doses, respectively.
The similar preliminary estimates for rats are that 
the growth of the females decreased slightly after 9 
weeks on either the low or the high dose. Mortality 
among the male rats increased after 47 weeks on the 
high dose and after 60 weeks on the low dose; that 
among female rats increased after 28 weeks on the 
high dose and after 31 weeks on the low dose. The 
incidences of gastric cancer were 76%  on the low 
dose and 59%  on the high dose. In the females, 
adenocarcinoma of the breast appeared in 48%  of 
the rats on the low dose and 62%  of those on the 
high dose. In both sexes of this species, there were 
appreciable occurrences of other malignant and be­
nign tumors (5 0 %  and 18%  in males on the low 
and high doses, respectively, and 14%  and 20%  in 
the females on the low and high doses). The most 
common of these tumors were hemangiomas and 
hemangiosarcomas.
Among the control rats, mammary carcinoma 
occurred in 10%  of the female colony controls and 
in none of the vehicle controls. Hemangiomas or 
hemangiosarcomas occurred in about 5.3%  of male 
colony control rats and 15%  of the females; they 
appeared in 5.0%  of female vehicle control rats and 
in none of the male ones. Cancer of the forestomach 
was found in no control rats or mice.
Toxic nephropathy was found in 23-9%  of male 
mice and 28%  of female mice on the low dose and 
in 93.7%  of male and female mice on the high dose 
of DBCP. Among fats, this type of lesion was found 
in 100%  of both male and female rats on the low 
dose o f DBCP and in 98%  and 100%  of the male 
and female rats, respectively, on the high dose of this 
compound.
W ard and Haberm ann (1 9 7 4 ), perhaps using 
some of the animals from the study just summarized, 
reported that the squamous cell carcinomas of the 
forestomach induced in mice and rats by gavage of 
DBCP directly into the stomach invaded the wall of 
the stomach and metastasized in peritoneal surfaces, 
especially in rats. The metastatic tumors frequently 
were associated with peritonitis and abscesses.
On the basis o f these studies with experimental 
animals, DBCP appears to have only slight irritative
reffect on intact skin or serous surfaces o f  the body, 
but to be somewhat m ore irritative o f  respiratory 
mucous membranes. In two rodent species, it appears 
to be carcinogenic, affecting mammary tissue in the 
fem ale rat and producing invasive gastric carcinomas 
after direct introduction into the stomachs o f  either 
sex o f  mice and rats. M alignant neoplasms have not 
been reported in rats exposed to vaporized D B C P  
in concentrations that killed 40 to 50%  o f  the ex­
posed anim als and that lasted for long enough to 
allow the appearance o f  mammary carcinomas in the 
exposed fem ales if  a time course similar to that fo l­
low ing gavage obtained. The likelihood o f  induc­
tion o f m alignancies by occupational exposures to 
D B C P  is difficult to predict from  these studies, there­
fore. It seems possible that, if  ingestion o f  D B C P  
can be avoided, there will be sm all, if any, prob­
ability that exposure to D B C P  will induce cancer. 
On the other hand, no one can be certain at present 
that this is true. In addition, the undoubted activity 
o f  this nematocide in disturbing reproductivity physi­
ology, which has been demonstrated in the male 
employee but apparently has not been recognized ir. 
the female, a n d . in producing renotoxic and hepato- 
toxic effects in rodents indicate that dedicated efforts 
to minimize exposure to this compound are necessary. 
There is no good quantitative basis for an occupa­
tional exposure limit, but the finding by Rakhmatu- 
layev (1 9 7 1 )  that repeated daily doses o f  0.05 m g /k g
o f  D B C P  to male rats eventually produced decreases 
in the weight o f  the testes and in the phagocytic 
activity o f the polym orphonuclear leucocytes indicate 
that the occupational exposure level should be set 
at a ceiling o f  0.1 m g /cu  m (O .O lppm ). T h is figure 
is based on a daily ventilatory exchange o f 18 cu m 
by a 70 kg man during a 10-hour work day. I f  all the 
D B C P  inhaled were retained in the employee’s body, 
this would yield a daily dose o f  0 .0257  m g /k g  to the 
standard man.
Th e draft report o f  a 90-day study o f  the inhala­
tion toxicity o f  D B C P  (H azelton  Laboratories A m er­
ica, 1976) indicates that both rats and mice exposed  
for 6 hours a day, on 5 days in each o f 13 weeks, to 
concentrations o f  this compound just above 1 ppm  
underwent slight, but definite, changes in the rate o f  
growth and in pellation. These findings indicate that 
the ceiling recommended gives a probable m argin o f  
safety for man o f  close to 100.
Com parison o f  the qualitative and quantitative 
actions o f  ethylene dibrom ide (See N IO S H ’s Criteria 
Document for a review) and D B C P  demonstrates 
that, although the two com pounds are sim ilar in their 
abilities to induce gastric cancers by gavage but ap ­
parently not by other routes o f  adm inistration, D B C P  
has actions that have not been reported fo r ethylene 
dibromide. Furthermore, it appears to be 10 to 20 
times as potent as ethylene dibromide.
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